Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amphastar Pharma (AMPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 790,506
  • Shares Outstanding, K 46,610
  • Annual Sales, $ 240,180 K
  • Annual Income, $ 4,510 K
  • 36-Month Beta 1.33
  • Price/Sales 3.27
  • Price/Cash Flow 23.08
  • Price/Book 2.40

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.65 +5.43%
on 05/31/18
17.22 -4.18%
on 06/19/18
-0.13 (-0.78%)
since 05/18/18
3-Month
14.40 +14.58%
on 05/10/18
19.94 -17.25%
on 04/18/18
-2.94 (-15.12%)
since 03/20/18
52-Week
14.40 +14.58%
on 05/10/18
20.45 -19.32%
on 03/14/18
-0.64 (-3.73%)
since 06/20/17

Most Recent Stories

More News
Amphastar Announces Approval for Isoproterenol Hydrochloride Injection, USP

Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has granted approval of its abbreviated new drug application ("ANDA") for Isoproterenol Hydrochloride...

AMPH : 16.50 (-2.71%)
New Strong Sell Stocks for June 14th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

BRS : 13.74 (+0.66%)
BGG : 18.74 (-0.11%)
AMPH : 16.50 (-2.71%)
DOV : 73.56 (-1.17%)
CHA : 45.21 (+0.16%)
Consolidated Research: 2018 Summary Expectations for Summit Therapeutics, Orbotech, Amphastar Pharmaceuticals, Mizuho Financial Group, Endo International plc, and AXT -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Summit Therapeutics PLC (NASDAQ:SMMT),...

AXTI : 7.60 (+2.70%)
ENDP : 9.43 (-0.11%)
SMMT : 13.25 (+11.44%)
ORBK : 62.84 (-0.03%)
AMPH : 16.50 (-2.71%)
MFG : 3.43 (-1.15%)
Moving Average Crossover Alert: Amphastar Pharmaceuticals, Inc. (AMPH)

Moving Average Crossover Alert: Amphastar Pharmaceuticals, Inc. (AMPH)

AMPH : 16.50 (-2.71%)
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference 2018

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, will be presenting at the Jefferies Healthcare Conference on Tuesday, June 5, 2018 at 3:00 p.m. Eastern Time in New...

AMPH : 16.50 (-2.71%)
Amphastar Pharmaceuticals Receives FDA Approval for Semi-Purified Heparin at Amphastar Nanjing Pharmaceuticals

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") granted approval of the company's abbreviated new drug application ("ANDA") supplement for the...

AMPH : 16.50 (-2.71%)
New Strong Sell Stocks for June 1st

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

VLVLY : 16.2450 (+0.12%)
OFIX : 60.75 (+0.53%)
CNDT : 20.39 (-1.83%)
AMPH : 16.50 (-2.71%)
EGHT : 19.95 (+1.01%)
New Strong Sell Stocks for May 29th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

BHVN : 41.34 (-2.25%)
CRUS : 38.14 (+0.74%)
DY : 99.42 (+0.45%)
AMPH : 16.50 (-2.71%)
BGCP : 12.41 (+7.08%)
New Strong Sell Stocks for May 22nd

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

CERN : 61.06 (-0.51%)
VLVLY : 16.2450 (+0.12%)
AHL : 41.90 (-1.18%)
AACAY : 14.8650 (-0.44%)
AMPH : 16.50 (-2.71%)
Falling Earnings Estimates Signal Weakness Ahead for Amphastar (AMPH)

Amphastar (AMPH) has witnessed a significant price decline in the past four weeks, and has seen negative earnings estimate revisions for the current quarter and year.

AMPH : 16.50 (-2.71%)
EVOK : 2.71 (-0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade AMPH with:

Business Summary

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and...

See More

Key Turning Points

2nd Resistance Point 17.26
1st Resistance Point 16.88
Last Price 16.50
1st Support Level 16.30
2nd Support Level 16.10

See More

52-Week High 20.45
Fibonacci 61.8% 18.14
Fibonacci 50% 17.42
Fibonacci 38.2% 16.71
Last Price 16.50
52-Week Low 14.40

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar